Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...

The registry data suggest improved outcomes without safety concerns, but confirmatory RCTs are needed, a researcher says.

New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When ...

In patients with acute ischemic stroke and elevated high-sensitivity cardiac troponin (hs-cTn), dynamic changes in hs-cTn are not helpful in identifying myocardial infarction (MI) or distinguishing MI ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Please provide your email address to receive an email when new articles are posted on . TNKase is the first stroke treatment approved by the FDA in almost 30 years, the manufacturer said. It is ...

All hospitals were already participating in the Get With The Guidelines-Stroke program and providing excellent care.

For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...

A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...

Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.